Archives by Month:

Archives by Year:

Facebook Is (Once Again) Cracking Down On Spammy Posts

Facebook Is (Once Again) Cracking Down On Spammy Posts

“BUY THIS!” “INSTALL NOW!’ “CONTEST!” Facebook (FB) is about to start punishing business Pages that publish spammy, aggressive marketing posts with these kind of words to the News Feed. Facebook will show them to a lot fewer of their fans, even if the Page paid for ads to get those fans. After a study of 500,000 users found they […]
Billion Gallons Of Fracking Wastewater Pumped Into Clean California Aquifiers: “Errors Were Made” State Admits

Billion Gallons Of Fracking Wastewater Pumped Into Clean California Aquifiers: “Errors Were Made” State Admits

Dear California readers: if you drank tapwater this morning (or at any point in the past few weeks/months), you may be in luck as you no longer need to buy oil to lubricate your engine: just use your blood, and think of the cost-savings. That’s the good news. Also, the bad news, because as the […]
Work Hard And Invest In The Future: Financial Review

Work Hard And Invest In The Future: Financial Review

Financial Review: DOW + 13 = 17,647 SPX + 1 = 2041 NAS – 17 = 4671 10 YR YLD + .02 = 2.34% OIL – .37 = 75.45 GOLD – 2.00 = 1187.50 SILV – .18 = 16.24 Another day, another record on Wall Street. A record high close for the S&P 500. The […]
Russell 2000 Experiences Increased Selling Pressure

Russell 2000 Experiences Increased Selling Pressure

In real terms, today’s selling in the Russell 2000 was relatively light, but it was the only business in town. The selling brought the index back to handle support, but it hasn’t violated the gap, and there is a 50-day MA which ‘golden crossed’ with the 200-day MA to provide support.   The S&P edged […]
How To Stay One Move Ahead In The Game

How To Stay One Move Ahead In The Game

One of my favorite hobbies is playing chess. Apart from the challenge of checkmating my opponent, I enjoy the lateral thinking, planning, and strategic thinking skills that are involved in the game. Recently, I was privileged to interview Israel’s top chess player, Grandmaster Boris Gelfand, on The Goldstein on Gelt Show. When I asked him […]
3 Reasons Why Investors Are Confident Ahead Of Home Depot Earnings Tuesday

3 Reasons Why Investors Are Confident Ahead Of Home Depot Earnings Tuesday

(Photo Credit: Mike Mozart) Home Depot (HD) is set to report earnings for the third quarter of the year on Tuesday, November 18 before the market opens. Over the past couple years Home Depot’s performance has been improving on the bottom line, the company has been buying back stock, and a recent pickup in housing […]
Earnings And Economic Reports: Week Starting 17 November

Earnings And Economic Reports: Week Starting 17 November

by Merlin Rothfeld, Online Trading Academy Econintersect: Here is a day-by-day rundown of the global economic calendar events for the coming week and the important earnings announcements each day, as well. Running length 7:19
E
                                                
                        Lesson: How To Trade 90% Accurately

E Lesson: How To Trade 90% Accurately

Anybody can look at the top gainers list every morning, throw 10 darts and hit 50% of the day trades. Some with actual experience can get to 70% accuracy. Now, with a system and process used based on self belief and expectancy you can get to 85% accuracy. This lesson shows you how to get […]
Gold Daily And Silver Weekly Charts – Knowledge Without Wisdom

Gold Daily And Silver Weekly Charts – Knowledge Without Wisdom

“Knowledge without wisdom is a load of books on the back an ass” The lesson to be learned from this will be hard indeed. Madness.      
E
                                                
                        Celldex Therapeutics Surges 30% After Positive Phase 2 Data In Brain Cancer

E Celldex Therapeutics Surges 30% After Positive Phase 2 Data In Brain Cancer

Shares of Celldex Therapeutics (CLDX) surged as much as 30% today after the company disclosed that it achieved positive results in patients with recurrent brain cancer in an interim phase 2 analysis. The phase 2 study, known as the REACT study, uses the company’s drug known as Rindopepimut to target patients with recurrent Glioblastoma — […]